![](https://immunomart.com/wp-content/uploads/2024/03/HY-128527.gif)
Download Files:
PROTAC ER Degrader-3
SKU
HY-128527-Get quote
Category Reference compound
Tags Cancer, Estrogen Receptor/ERR;PROTACs, PROTAC;Vitamin D Related/Nuclear Receptor
Products Details
Product Description
– PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab)[1].
Web ID
– HY-128527
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C71H77N7O12
References
– [1]Thomas Pillow, et al. Protac antibody conjugates and methods of use. WO2017201449A1.
CAS Number
– 2158322-29-1
Molecular Weight
– 1220.41
SMILES
– OC1=CC=C(/C(C2=CC=C(OCCN(C)C(COCCOCCNC(C3=CC=C(C(N4[C@@H](C)[C@H](NC([C@H](C)N(C(OC(C)(C)C)=O)C)=O)C(N(CC5=C(OC)C=CC6=C5C=CC=C6)C7=C4C=C(C#N)C=C7)=O)=O)C=C3)=O)=O)C=C2)=C(CC)/C8=CC=CC=C8)C=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Estrogen Receptor/ERR;PROTACs
Pathway
– PROTAC;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.